Glomerulonephritis, IGA  >>  Tavalisse (fostamatinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tavalisse (fostamatinib) / Rigel
NCT02433236: Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy

Withdrawn
2
0
US, Europe, RoW
Fostamatinib Disodium tablet 100 mg, Fostamatinib, R788, Fostamatinib Disodium tablet 150 mg
Rigel Pharmaceuticals
IGA Nephropathy
09/15
 

Download Options